A switch from current HMG CoA reductase inhibitor [statin] therapy to either cerivastatin 0.4 or 0.8 mg/day or simvastatin 80 mg/day

By  

Inpharma, Vol. 1, Iss. 1307, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Statin Therapy

By  

Current Pharmaceutical Design, Vol. 18, Iss. 38, 2012-12 ,pp. : 6284-6290

Bentham Science Publishers

Access to resources Recommend Favorite

To switch (statins) or not to switch? That is the question

By Athyros Vasilios G   Tziomalos Konstantinos   Karagiannis Asterios   Mikhailidis Dimitri P  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 18, 2010-12 ,pp. : 2943-2946

Informa Healthcare

Access to resources Recommend Favorite

Statin use linked with impotence

By  

Inpharma, Vol. 1, Iss. 1531, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Risk assessment with statin therapy

By listed n.l.n.  

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 5, 2001-10 ,pp. : 221-222

Adis International

Access to resources Recommend Favorite